Cargando…

Free Water in White Matter Differentiates MCI and AD From Control Subjects

Recent evidence shows that neuroinflammation plays a role in many neurological diseases including mild cognitive impairment (MCI) and Alzheimer's disease (AD), and that free water (FW) modeling from clinically acquired diffusion MRI (DTI-like acquisitions) can be sensitive to this phenomenon. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumont, Matthieu, Roy, Maggie, Jodoin, Pierre-Marc, Morency, Felix C., Houde, Jean-Christophe, Xie, Zhiyong, Bauer, Cici, Samad, Tarek A., Van Dijk, Koene R. A., Goodman, James A., Descoteaux, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783505/
https://www.ncbi.nlm.nih.gov/pubmed/31632265
http://dx.doi.org/10.3389/fnagi.2019.00270
_version_ 1783457568587251712
author Dumont, Matthieu
Roy, Maggie
Jodoin, Pierre-Marc
Morency, Felix C.
Houde, Jean-Christophe
Xie, Zhiyong
Bauer, Cici
Samad, Tarek A.
Van Dijk, Koene R. A.
Goodman, James A.
Descoteaux, Maxime
author_facet Dumont, Matthieu
Roy, Maggie
Jodoin, Pierre-Marc
Morency, Felix C.
Houde, Jean-Christophe
Xie, Zhiyong
Bauer, Cici
Samad, Tarek A.
Van Dijk, Koene R. A.
Goodman, James A.
Descoteaux, Maxime
author_sort Dumont, Matthieu
collection PubMed
description Recent evidence shows that neuroinflammation plays a role in many neurological diseases including mild cognitive impairment (MCI) and Alzheimer's disease (AD), and that free water (FW) modeling from clinically acquired diffusion MRI (DTI-like acquisitions) can be sensitive to this phenomenon. This FW index measures the fraction of the diffusion signal explained by isotropically unconstrained water, as estimated from a bi-tensor model. In this study, we developed a simple but powerful whole-brain FW measure designed for easy translation to clinical settings and potential use as a priori outcome measure in clinical trials. These simple FW measures use a “safe” white matter (WM) mask without gray matter (GM)/CSF partial volume contamination (WM(safe)) near ventricles and sulci. We investigated if FW inside the WM(safe) mask, including and excluding areas of white matter damage such as white matter hyperintensities (WMHs) as shown on T2 FLAIR, computed across the whole white matter could be indicative of diagnostic grouping along the AD continuum. After careful quality control, 81 cognitively normal controls (NC), 103 subjects with MCI and 42 with AD were selected from the ADNIGO and ADNI2 databases. We show that MCI and AD have significantly higher FW measures even after removing all partial volume contamination. We also show, for the first time, that when WMHs are removed from the masks, the significant results are maintained, which demonstrates that the FW measures are not just a byproduct of WMHs. Our new and simple FW measures can be used to increase our understanding of the role of inflammation-associated edema in AD and may aid in the differentiation of healthy subjects from MCI and AD patients.
format Online
Article
Text
id pubmed-6783505
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67835052019-10-18 Free Water in White Matter Differentiates MCI and AD From Control Subjects Dumont, Matthieu Roy, Maggie Jodoin, Pierre-Marc Morency, Felix C. Houde, Jean-Christophe Xie, Zhiyong Bauer, Cici Samad, Tarek A. Van Dijk, Koene R. A. Goodman, James A. Descoteaux, Maxime Front Aging Neurosci Neuroscience Recent evidence shows that neuroinflammation plays a role in many neurological diseases including mild cognitive impairment (MCI) and Alzheimer's disease (AD), and that free water (FW) modeling from clinically acquired diffusion MRI (DTI-like acquisitions) can be sensitive to this phenomenon. This FW index measures the fraction of the diffusion signal explained by isotropically unconstrained water, as estimated from a bi-tensor model. In this study, we developed a simple but powerful whole-brain FW measure designed for easy translation to clinical settings and potential use as a priori outcome measure in clinical trials. These simple FW measures use a “safe” white matter (WM) mask without gray matter (GM)/CSF partial volume contamination (WM(safe)) near ventricles and sulci. We investigated if FW inside the WM(safe) mask, including and excluding areas of white matter damage such as white matter hyperintensities (WMHs) as shown on T2 FLAIR, computed across the whole white matter could be indicative of diagnostic grouping along the AD continuum. After careful quality control, 81 cognitively normal controls (NC), 103 subjects with MCI and 42 with AD were selected from the ADNIGO and ADNI2 databases. We show that MCI and AD have significantly higher FW measures even after removing all partial volume contamination. We also show, for the first time, that when WMHs are removed from the masks, the significant results are maintained, which demonstrates that the FW measures are not just a byproduct of WMHs. Our new and simple FW measures can be used to increase our understanding of the role of inflammation-associated edema in AD and may aid in the differentiation of healthy subjects from MCI and AD patients. Frontiers Media S.A. 2019-10-02 /pmc/articles/PMC6783505/ /pubmed/31632265 http://dx.doi.org/10.3389/fnagi.2019.00270 Text en Copyright © 2019 Dumont, Roy, Jodoin, Morency, Houde, Xie, Bauer, Samad, Van Dijk, Goodman and Descoteaux. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Dumont, Matthieu
Roy, Maggie
Jodoin, Pierre-Marc
Morency, Felix C.
Houde, Jean-Christophe
Xie, Zhiyong
Bauer, Cici
Samad, Tarek A.
Van Dijk, Koene R. A.
Goodman, James A.
Descoteaux, Maxime
Free Water in White Matter Differentiates MCI and AD From Control Subjects
title Free Water in White Matter Differentiates MCI and AD From Control Subjects
title_full Free Water in White Matter Differentiates MCI and AD From Control Subjects
title_fullStr Free Water in White Matter Differentiates MCI and AD From Control Subjects
title_full_unstemmed Free Water in White Matter Differentiates MCI and AD From Control Subjects
title_short Free Water in White Matter Differentiates MCI and AD From Control Subjects
title_sort free water in white matter differentiates mci and ad from control subjects
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783505/
https://www.ncbi.nlm.nih.gov/pubmed/31632265
http://dx.doi.org/10.3389/fnagi.2019.00270
work_keys_str_mv AT dumontmatthieu freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT roymaggie freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT jodoinpierremarc freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT morencyfelixc freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT houdejeanchristophe freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT xiezhiyong freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT bauercici freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT samadtareka freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT vandijkkoenera freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT goodmanjamesa freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT descoteauxmaxime freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects
AT freewaterinwhitematterdifferentiatesmciandadfromcontrolsubjects